ARTICLE | Company News
Aventis to evaluate BioVex technology
June 11, 2001 7:00 AM UTC
Gene delivery company BioVex (London, U.K.) signed two evaluation agreements with Aventis (AVE) in target validation and delivery. AVE will test the ability of BioVex's GenTest NeuroVex vectors to eff...